Catana, Fe C.

HRN: 25-59-18  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/06/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/06/2026
06/12/2026
IV
4.5g
Q6h
Acute Cholecystitis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: